Hashimoto’s Thyroiditis Drug Industry: Global Hashimoto’s thyroiditis drug Current Status and Future Prospects
According to various studies, Hashimoto's thyroiditis affects around 5-10% of the global population. Hashimoto’s Thyroiditis Drug is considered to be more common in women than in men, with a female to male ratio of around 8:1. The rates also peak at different ages for women compared to men. For women, the prevalence peaks between the ages of 30-50 years, while for men, it is between 60-70 years. Some of the countries with highest reported rates of Hashimoto's thyroiditis include the United States, Japan, Denmark, Sweden and other developed nations. Geographic variations indicate the role of both genetic and environmental factors in its pathogenesis.
(https://www.coherentmarketinsi....ghts.com/industry-re
